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ABSTRACT 
Objective: 
 
To determine the “hand anatomic index” (HAI - a quantitative measure of hand 
deformity)  in systemic sclerosis (scleroderma) and to compare it with other measures 
of hand deformity and functional impairment. 
Methods: 
The HAI (measure of open hand span minus closed hand span/lateral height of hand) 
was determined in 30 patients with scleroderma and compared with hand deformity 
(as assessed by two independent rheumatologists) and  with the Health Assessment 
Questionnaire (mHAQ), hand strength and prehensile gripability data. 
Results: 
The HAI was confirmed as a reliable measure which clearly distinguished patients 
with increasing hand deformity and separated patients with diffuse scleroderma 
(n=12) from limited scleroderma (n=18), p=0.005.  The HAI correlated significantly 
with measures of global functional impairment (as measured by the MHAQ) r=-0.46, 
p=0.01, hand strength r=0.51, p=0.0001 and prehensile gripability, r=-0.37, p=0.05 
but not with disease duration r=-0.16, p=NS nor age at disease onset r=0.20, p=NS.  It 
was estimated that the HAI accounts for ~25% of the total global disability (as 
measured by HAQ).  
Conclusion: 
Measurement of the HAI in scleroderma provides a reliable and objective measure 
reflecting variable degrees of hand deformity and functional impairment and might 
provide a valid clinical outcome measure in patients with this disabling disorder.   
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Impairment.  
A simple quantitative measurement of hand deformity in scleroderma would be a 
valuable clinical parameter particularly in the initial assessment of such patients and 
their subsequent follow up.  Furthermore such an assessment of hand deformity might 
also closely relate to functional impairment, a clinical measure of much importance. 
Recently Highton and colleagues1 have derived a hand anatomic index (HAI) from the 
measurements of certain hand dimensions and have shown it can clearly distinguish 
patients with rheumatoid arthritis (RA) from healthy controls.  Additionally these 
investigators showed in their rheumatoid patients a significant correlation between 
this HAI and measure of disease duration, disease activity and functional impairment 
(as assessed by the modified Health Assessment Questionnaire (HAQ). They provided 
strong evidence, therefore, in support of their hypothesis that quantitative 
measurements of visible, structural abnormalities of the hands will detect the presence 
of RA and reflect its severity.  
We have therefore derived this same HAI in 30 patients with scleroderma and 
compared it with a number of validated functional measurements. Our results support 
the notion that the determination of the HAI might provide a simple and clinically 
relevant measure of impairment of hand function in this enigmatic and frequently 
disabling disorder.  
METHODS 
Patients  
Thirty patients with scleroderma were selected arbitrarily (i.e. without prior 
knowledge of their disease subtype or severity) from the South Australian 
Scleroderma Register2 according to their geographic accessibility (i.e. closeness to 
research unit) and their willingness to participate in the study.  Twelve of these 
patients had diffuse scleroderma and 18 limited scleroderma ( with the disease  being  
subtyped according to the criteria as discussed by LeRoy and colleagues3). The 
demographics, disease subtype, disease characteristic and serology of this patient 
cohort are listed in Table 1. 
Hand Anatomic Index 
The HAI was determined by the method of Highton1 with the modification that 
callipers and ruler were used to determine the three hand dimensions rather than the 
determination using a computerised video imaging analytical program as initially 
described.  The HAI is defined as the measurement of maximum hand spread (a) 
minus measurement of closed hand span (b) divided by measurement of maximum 
lateral hand height (c) (i.e. (a-b)·c  where a = distance of maximum hand spread 
measured from middle tip of thumb to middle tip of fifth digit, b = distance of closed 
hand with thumb lying extended against index finger from middle tip of thumb to 
middle tip of fifth digit and c = distance of maximum hand height (from lateral view 
of open hand – generally from the apex of the most prominent MCP joint to the 
base)).  The HAI was determined for both dominant and non dominant hands with the 
HAI (m) being the mean of the two values.         
  
Functional Assessments 
Health Assessment Questionnaire (HAQ). Patients were requested to complete a 
modified HAQ4  
Hand Grip Strength 
Hand grip strength was measured using a calibrated Jamar dynamometer according to 
the standardised method of Fess5. 
Prehensile Hand Gripability  
Prehensile hand gripability as measured according to the method of Dellehag6. In brief 
the gripability test was scored according to the combined time to complete 3 separate 
tasks, viz 1) placing flexi grip stocking over the non-dominant hand, 2) positioning of 
a paper clip on an envelope and 3) pouring water from a plastic jug into a cup.  
Digital Photography 
Digital photography of the hands in 3 views (antero-posterior view of hand in 
extended and closed position and lateral view of open hand) were obtained for each 
patient. Hand deformity was assessed by having 2 rheumatologists in a blinded but 
concasual fashion grade these images as normal, mild, moderate or grossly deformed 
Ethics  
The project had the approval of the Flinders Clinical Research Ethics Committee with 
all patients giving written consent to participate in the study. 
Statistical Analysis 
In general non-parametric statistical tests (Stata version 8 software) were used with a 
p value <0.05 being considered significant. Test-retest reliability was determined by 
intraclass correlation coefficient.   Comparison between groups was performed using 
the Mann-Whitney test while correlation between two variables was assessed using 
Spearman rank-order correlation coefficients (r).  
 RESULTS 
To confirm reliability of the HAI we measured the 3 specific hand dimensions on two 
occasions in 5 patients. Calculated test-retest reliability correlation coefficient was 
0.994.           
The  HAI (m)  was then correlated with hand deformity as assessed in a blinded 
fashion by 2 independent senior rheumatologists viewing 3 hand digital photographs 
from each patient.  A progressive decline in the mean HAI was observed between 
hands graded as normal to those with gross deformity (r=-0.77, p=0:0000, Figure 1).  
 Patients were then divided into those with limited and diffuse cutaneous scleroderma 
and the HAI (m) plotted (Figure 2).  Patients with diffuse scleroderma had 
significantly lower values that those with limited scleroderma (p = 0.005, Mann-
Whitney). The HAQ (m) was then correlated with HAQ score, hand strength, hand 
gripability, age at onset, and disease duration and the results are tabulated (Table II) 
and selected scatter plots are shown Figures 3, 4 and 5.  Of particular interest was the 
significant correlation observed between the HAI (m) with other measures of hand 
functions and global disability (as measured by the HAQ). It was established by 
regression analysis that the HAI (m) accounts for ~ 25% of the total HAQ variance. 
DISCUSSION 
We describe a simple and reliable measure of  quantifying hand anatomical deformity 
in scleroderma, have noted that it can discriminate significantly between patients with 
diffuse and limited cutaneous scleroderma and have then correlated this HAI with 
other measures of hand functional impairment and global impairment.  We conclude 
that the HAI appears to have good construct validity in scleroderma but that further 
studies will be required to test its sensitivity to change over time.  
 
The HAI was recently described by one of us1 (JH) and was shown to produce a 
reliable measure to reflect the progression of anatomical abnormality of the hand 
caused by rheumatoid arthritis. As such it was suggested that it might provide a useful 
outcome measure in rheumatoid arthritis1.  
 
Hand deformity with disability is a prominent feature in scleroderma and we have 
therefore determined the HAI in 30 patients with this disease. In order to further 
simplify the measurement of the HAI we have modified the original description by 
removing the need for computerised video image analysis – we have merely measured 
the necessary hand dimensions using a calliper and ruler.  We have verified that this is 
a reliable measure by replicating our measures in the same patient thus confirming its 
reproducibility.  Further we have shown that the HAI will clearly distinguish between 
patients with diffuse and limited scleroderma the former having greater anatomical 
deformity as would be expected by the greater degree of flexural contractures and 
joint immobility seen in this more severe variant.  In addition the HAI also correlated 
significantly with other measures of hand dysfunction and with the HAQ measure of 
global functional impairment.  This is not unexpected as the hand is especially 
important in performing the activities of daily living as assessed in the HAQ.  Indeed 
we established that the HAI accounts for approximately 25% of the total variance of 
the HAQ score.  The positive correlations of the HAI with hand function and global 
disability together with the lack of correlation of the HAI with age at disease onset 
and with disease duration would be consistent with the HAI having good construct 
validity in scleroderma.  
It is of interest that the severity of the hand deformity in our diffuse scleroderma 
patients (as assessed by the HAI) is of a similar order of magnitude as is found in 
longstanding rheumatoid arthritis.  Highton et al1 quotes a HAI for healthy control 
subjects (of similar gender ratio and age range to our own patients) of 3.76 + 0.6 (SD) 
versus 1.51 + 0.9 in his rheumatoid arthritis patients.  This latter figure is very similar 
to that observed for our diffuse scleroderma patients.  Furthermore we have recently 
determined in a study involving 35 patients with diffuse scleroderma that the global 
functional impairment of these patients is likewise very similar to patients with 
rheumatoid arthritis (mean mHAQ + 95% Cl for diffuse scleroderma = 0.82 (0.55-
1.08) as compared with 1.03 (0.88-1.21) for 170 rheumatoid arthritis patients, 
unpublished observations).  
There are a number of publications assessing hand function in RA, OA and 
Scleroderma 7-11  both of a quantitative nature (i.e.range of motion, grip strength, 
dexterity ) and of a qualitative nature (i.e. pain, self-efficacy) and many  have been 
validated.  Recently the Cochin hand function scale CHFS (an 18 point questionnaire) 
has been shown to have favourable construct validity in scleroderma6 with the CHFS 
total score explaining 75% of the HAQ global score variance (as assessed by 
ANOVA). We are now proceeding to compare the HAI with the CHFS. It would seem 
most efficient to have one qualitative assessment (eg CHFS) and one quantitative 
assessment (eg HAI) to comprehensively assess hand function in scleroderma, for the 
purpose of sequential monitoring. However in both these measures further research 
will be necessary to assess the sensitivity to change over time.  
In conclusion measurement of the HAI in patients with scleroderma reliably reflects 
hand deformity/functional impairment and might provide a valuable outcome measure 
in this disabling rheumatic disorder.  
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TABLE 1 
CHARTERISTICS OF PATIENTS WITH SCLERODERMA  
 
  No   Gender            Mean Age   Mean Disease          Serology  
         Male:Female   years (range)   Duration (range)     (antibody)  
12 4:8 50.3 (39-68) 10.8 (2-18) Scl-70 = 3 Diffuse 
Limited 18 2:16 64.5 (36-84) 23.6 (4-64) centromere = 7 
 
   
 TABLE II  
 
CORRELATION OF HAND ANATOMIC INDEX WITH OTHER HAND 
FUNCTIONAL INDICES AND DISEASE CHARACTERISTICS 
            
HAQ HAND 
STRENGTH 
(av) 
HAND 
GRIPABILITY  
AGE AT 
ONSET 
DISEASE 
DURATION  
r=-0.46 
 
r=0.51 r=-0.37 r=0.20 r=-0.16 
 
 
 
Hand 
anatomical  
Index (av) p=0.01+ p=0.0001 p=0.05 p=NS p=NS 
 
 correlation coefficient (Spearman) 
p+ = p value.  NS – not significant  
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LEGEND TO FIGURES 
Figure 1 
Hand deformity as graded by 2 senior rheumatologists into 4 grades (x abscissa) and 
plotted against the HAI (y ordinate).  Each point represent a patient and the horizontal 
bars represent the means for the 4 catagories. (n=29 patients only). 
Figure 2 
Box and wisker demonstration of HAI (m) between patients with diffuse cutaneous 
scleroderma (n=12) and limited cutaneous scleroderma (n=18) p=0.005.  The box 
demonstrates the mean and 25th  and 75th  percentile while the wisker indicate the 5th 
and 95th percentile. 
Figure 3 
Correlation between HAI (m) and HAQ.  Spearman r=-0.46, p=0.01.  
Figure 4 
Correlation between HAI (m) and hand strength. Spearman r=0.51, n=0.0001. 
Figure 5 
Correlation between HAI (m) and hand prehensile gripability. Spearman r= -0.37, 
p=0.05. 
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Key Messages: 
x The hand anatomic index (HAI) (open hand span minus closed hand 
span/lateral height of hand) is a simple, reliable and quantitative measure of 
hand deformity. 
x The HAI determined in 30 patients with scleroderma clearly distinguished 
patients with increasing hand deformity and correlated significantly with 
measures of hand strength (p=0.0001), prehensile gripability (p=0.05) and 
global functional impairment (as measured by the Health Assessment 
questionnaire p=0.01). 
x Measurement of the HAI in scleroderma (and in rheumatoid arthritis) is a 
reliable and objective measure of hand deformity and functional impairment 
and might provide a useful clinical outcome measure.  Its sensitivity to change 
over time needs to be determined.  
